- Home
- PBHC vs LXEO Comparison
PBHC vs LXEO Comparison
Compare PBHC & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBHC
- LXEO
- Stock Information
- Founded
- PBHC 1859
- LXEO 2017
- Country
- PBHC United States
- LXEO United States
- Employees
- PBHC N/A
- LXEO N/A
- Industry
- PBHC Major Banks
- LXEO
- Sector
- PBHC Finance
- LXEO
- Exchange
- PBHC Nasdaq
- LXEO Nasdaq
- Market Cap
- PBHC 92.1M
- LXEO 93.9M
- IPO Year
- PBHC N/A
- LXEO 2023
- Fundamental
- Price
- PBHC $14.61
- LXEO $3.91
- Analyst Decision
- PBHC
- LXEO Strong Buy
- Analyst Count
- PBHC 0
- LXEO 5
- Target Price
- PBHC N/A
- LXEO $16.60
- AVG Volume (30 Days)
- PBHC 7.0K
- LXEO 719.7K
- Earning Date
- PBHC 07-28-2025
- LXEO 08-11-2025
- Dividend Yield
- PBHC 2.74%
- LXEO N/A
- EPS Growth
- PBHC N/A
- LXEO N/A
- EPS
- PBHC 0.53
- LXEO N/A
- Revenue
- PBHC $41,317,000.00
- LXEO N/A
- Revenue This Year
- PBHC N/A
- LXEO N/A
- Revenue Next Year
- PBHC N/A
- LXEO N/A
- P/E Ratio
- PBHC $27.73
- LXEO N/A
- Revenue Growth
- PBHC 1.46
- LXEO N/A
- 52 Week Low
- PBHC $12.30
- LXEO $1.45
- 52 Week High
- PBHC $19.86
- LXEO $19.50
- Technical
- Relative Strength Index (RSI)
- PBHC 41.32
- LXEO 55.22
- Support Level
- PBHC $14.81
- LXEO $3.62
- Resistance Level
- PBHC $15.95
- LXEO $4.29
- Average True Range (ATR)
- PBHC 0.27
- LXEO 0.45
- MACD
- PBHC -0.06
- LXEO 0.04
- Stochastic Oscillator
- PBHC 0.00
- LXEO 58.68
About PBHC Pathfinder Bancorp Inc. (MD)
Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.